Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer von Danson, S, Ferry, D, Alakhov, V, Margison, J, Kerr, D, Jowle, D, Brampton, M, Halbert, G, Ranson, M

Volltext

Phase I trial of temozolomide using an extended continuous oral schedule von BROCK, C. S, NEWLANDS, E. S, WEDGE, S. R, BOWER, M, EVANS, H, COLQUHOUN, I, RODDIE, M, GLASER, M, BRAMPTON, M. H, RUSTIN, G. J. S

Volltext

Phase I trial of elactocin von NEWLANDS, E. S, RUSTIN, G. J. S, BRAMPTON, M. H

Volltext

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma von BOWER, M, NEWLANDS, E. S, BLEEHEN, N. M, BRADA, M, BEGENT, R. J. H, CALVERT, H, COLQUHOUN, I, LEWIS, P, BRAMPTON, M. H

Volltext

The charing cross hospital experience with temozolomide in patients with gliomas von Newlands, E.S., O'Reilly, S.M., Glaser, M.G., Bower, M., Evans, H., Brock, C., Brampton, M.H., Colquhoun, I., Lewis, P., Rice-Edwards, J.M., Illingworth, R.D., Richards, P.G.

Volltext

Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer von BOOTE, D. J, DENNIS, I. F, TWENTYMAN, P. R, OSBORNE, R. J, LABURTE, C, HENSEL, S, SMYTH, J. F, BRAMPTON, M. H, BLEEHEN, N. M

Volltext

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma von BLEEHEN, N. M, NEWLANDS, E. S, LEE, S. M, THATCHER, N, SELBY, P, CALVERT, A. H, RUSTIN, G. J. S, BRAMPTON, M, STEVENS, M. F. G

Volltext

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856) von NEWLANDS, E. S, BLACKLEDGE, G. R. P, GIBSON, A. C, SLACK, J. A, RUSTIN, G. J. S, SMITH, D. B, STUART, N. S. A, QUATERMAN, C. P, HOFFMAN, R, STEVENS, M. F. G, BRAMPTON, M. H

Volltext

Effect of temozolomide on central nervous system relapse in patients with advanced melanoma von Paul, M J, Summers, Y, Calvert, A H, Rustin, G, Brampton, M H, Thatcher, N, Middleton, M R

Volltext

Infrared body temperature measurement of mice as an early predictor of death in experimental fungal infections von Warn, P A, Brampton, M W, Sharp, A, Morrissey, G, Steel, N, Denning, D W, Priest, T

Volltext

Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours von O'Reilly, S M, Newlands, E S, Glaser, M G, Brampton, M, Rice-Edwards, J M, Illingworth, R D, Richards, P G, Kennard, C, Colquhoun, I R, Lewis, P

Volltext

A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen von JOHNSTON, S. R. D, GUMBRELL, L. A, JONES, A, CANNEY, P, POWLES, T. J, HAYNES, B. P, NUTLEY, B, GRIMSHAW, R, JARMAN, M, HALBERT, G. W, BRAMPTON, M, HAVILAND, J, EVANS, T. R. J, DOWSETT, M, COOMBES, R. C, COLEMAN, R. E, SMITH, I. E, TWELVES, C. J, SOUKOP, M, REA, D. W, EARL, H. M, HOWELL, A

Volltext

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma von WOLL, P. J, CROWTHER, D, JOHNSON, P. W. M, SOUKOP, M, HARPER, P. G, HARRIS, M, BRAMPTON, M. H, NEWLANDS, E. S

Volltext

O6-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma von Middleton, MR, Lunn, JM, Morris, C, Rustin, G, Wedge, SR, Brampton, MH, Lind, MJ, Lee, SM, Newell, DR, Bleehen, NM, Newlands, ES, Calvert, AH, Margison, GP, Thatcher, N

Volltext

A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation von Estlin, E J, Pinkerton, C R, Lewis, I J, Lashford, L, McDowell, H, Morland, B, Kohler, J, Newell, D R, Boddy, A V, Taylor, G A, Price, L, Ablett, S, Hobson, R, Pitsiladis, M, Brampton, M, Clendeninn, N, Johnston, A, Pearson, A D J

Volltext

Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer von KERR, D. J, RUSTIN, G. J, KAYE, S. B, SELBY, P, BLEEHEN, N. M, HARPER, P, BRAMPTON, M. H

Volltext

A Cancer Research Campaign (CRC) phase II trial of CB10-277 given by 24 hour infusion for malignant melanoma von Bleehen, N M, Calvert, A H, Lee, S M, Harper, P, Kaye, S B, Judson, I, Brampton, M

Volltext

Phase II trial of didox in advanced breast cancer von RUBENS, R. D, KAYE, S. B, SOUKOP, M, WILLIAMS, C. J, BRAMPTON, M.H, HARRIS, A. L

Volltext

Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee von Rubens, R D, Kaye, S B, Soukop, M, Williams, C J, Brampton, M H, Harris, A L

Volltext

Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer von KAYE, S. B, BRAMPTON, M, HARPER, P, SMYTH, J, KERR, D. J, GORE, M, GREEN, J. A, GILBY, E, CRAWFORD, S. M, RUSTIN, G. J

Volltext